244 related articles for article (PubMed ID: 10438897)
21. Alterations in T cell phenotype and human immunodeficiency virus type 1-specific cytotoxicity after potent antiretroviral therapy.
Seth A; Markee J; Hoering A; Sevin A; Sabath DE; Schmitz JE; Kuroda MJ; Lifton MA; Hirsch MS; Collier AC; Letvin NL; McElrath MJ
J Infect Dis; 2001 Mar; 183(5):722-9. PubMed ID: 11181148
[TBL] [Abstract][Full Text] [Related]
22. In vitro effects of IL-12 on HIV-1-specific CTL lines from HIV-1-infected children.
McFarland EJ; Harding PA; MaWhinney S; Schooley RT; Kuritzkes DR
J Immunol; 1998 Jul; 161(1):513-9. PubMed ID: 9647263
[TBL] [Abstract][Full Text] [Related]
23. The PEDVAC trial: preliminary data from the first therapeutic DNA vaccination in HIV-infected children.
Palma P; Romiti ML; Li Pira G; Montesano C; Mora N; Aquilani A; Santilli V; Tchidjou HK; Ivaldi F; Giovannelli L; Pontrelli G; Borra G; Blomberg P; Gudmundsdotter L; Bråve A; Montano M; Bernardi S; Manca F; Wahren B; Rossi P
Vaccine; 2011 Sep; 29(39):6810-6. PubMed ID: 21216310
[TBL] [Abstract][Full Text] [Related]
24. DNA immunization with HIV-1 tat mutated in the trans activation domain induces humoral and cellular immune responses against wild-type Tat.
Caselli E; Betti M; Grossi MP; Balboni PG; Rossi C; Boarini C; Cafaro A; Barbanti-Brodano G; Ensoli B; Caputo A
J Immunol; 1999 May; 162(9):5631-8. PubMed ID: 10228047
[TBL] [Abstract][Full Text] [Related]
25. Persistent HIV-1-specific CTL clonal expansion despite high viral burden post in utero HIV-1 infection.
Brander C; Goulder PJ; Luzuriaga K; Yang OO; Hartman KE; Jones NG; Walker BD; Kalams SA
J Immunol; 1999 Apr; 162(8):4796-800. PubMed ID: 10202022
[TBL] [Abstract][Full Text] [Related]
26. Induction of HIV-1 Nef-specific cytotoxic T lymphocytes by Nef-expressing DNA vaccine.
Asakura Y; Hamajima K; Fukushima J; Mohri H; Okubo T; Okuda K
Am J Hematol; 1996 Oct; 53(2):116-7. PubMed ID: 8892736
[TBL] [Abstract][Full Text] [Related]
27. Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients.
Calarota S; Bratt G; Nordlund S; Hinkula J; Leandersson AC; Sandström E; Wahren B
Lancet; 1998 May; 351(9112):1320-5. PubMed ID: 9643795
[TBL] [Abstract][Full Text] [Related]
28. Interferon regulatory factor-1 acts as a powerful adjuvant in tat DNA based vaccination.
Castaldello A; Sgarbanti M; Marsili G; Brocca-Cofano E; Remoli AL; Caputo A; Battistini A
J Cell Physiol; 2010 Sep; 224(3):702-9. PubMed ID: 20432465
[TBL] [Abstract][Full Text] [Related]
29. Enhancement of cellular immune response in HIV-1 seropositive individuals: A DNA-based trial.
Boyer JD; Chattergoon MA; Ugen KE; Shah A; Bennett M; Cohen A; Nyland S; Lacy KE; Bagarazzi ML; Higgins TJ; Baine Y; Ciccarelli RB; Ginsberg RS; MacGregor RR; Weiner DB
Clin Immunol; 1999 Jan; 90(1):100-7. PubMed ID: 9884357
[TBL] [Abstract][Full Text] [Related]
30. Tumor necrosis factor alpha and human immunodeficiency virus-specific functional immune responses after immunization with Gp120-depleted, inactivated HIV-1 in incomplete Freund's adjuvant (REMUNE) in HIV-1-seropositive subjects.
Moss RB; Li L; Giermakowska WK; Lanza P; Turner JL; Wallace MR; Jensen FC; Richieri SP; Daigle AE; Theofan G; Carlo DJ
J Hum Virol; 1998; 1(2):77-81. PubMed ID: 10195235
[TBL] [Abstract][Full Text] [Related]
31. Modulation of cellular and humoral immune responses to a multiepitopic HIV-1 DNA vaccine by interleukin-18 DNA immunization/viral protein boost.
Billaut-Mulot O; Idziorek T; Loyens M; Capron A; Bahr GM
Vaccine; 2001 Apr; 19(20-22):2803-11. PubMed ID: 11282190
[TBL] [Abstract][Full Text] [Related]
32. A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption.
Allard SD; De Keersmaecker B; de Goede AL; Verschuren EJ; Koetsveld J; Reedijk ML; Wylock C; De Bel AV; Vandeloo J; Pistoor F; Heirman C; Beyer WE; Eilers PH; Corthals J; Padmos I; Thielemans K; Osterhaus AD; Lacor P; van der Ende ME; Aerts JL; van Baalen CA; Gruters RA
Clin Immunol; 2012 Mar; 142(3):252-68. PubMed ID: 22177848
[TBL] [Abstract][Full Text] [Related]
33. Delayed-type hypersensitivity responses to HIV Gag p24 relate to clinical outcome after peptide-based therapeutic immunization for chronic HIV infection.
Kran AM; Sommerfelt MA; Baksaas I; Sørensen B; Kvale D
APMIS; 2012 Mar; 120(3):204-9. PubMed ID: 22339677
[TBL] [Abstract][Full Text] [Related]
34. Pediatric HIV-1-specific cytotoxic T-lymphocyte responses suggesting ongoing viral replication despite combination antiretroviral therapy.
Ching N; Yang OO; Deville JG; Nielsen-Saines K; Ank BJ; Sim MS; Bryson YJ
Pediatr Res; 2007 Jun; 61(6):692-7. PubMed ID: 17426646
[TBL] [Abstract][Full Text] [Related]
35. Better preserved immune responses after immunization with rgp 160 in HIV-1 infected patients treated with highly active antiretroviral therapy than in untreated patients with similar CD4 levels during at 2 years' follow-up.
Hejdeman B; Leandersson AC; Fredriksson EL; Sandström E; Wahren B; Bratt G
HIV Med; 2003 Apr; 4(2):101-10. PubMed ID: 12702130
[TBL] [Abstract][Full Text] [Related]
36. Immunotherapy and therapeutic vaccines in HIV infection.
García F; Ruiz L; López-Bernaldo de Quirós JC; Moreno S; Domingo P
Enferm Infecc Microbiol Clin; 2005 Jul; 23 Suppl 2():84-104. PubMed ID: 16373008
[TBL] [Abstract][Full Text] [Related]
37. Mechanism of HIV persistence: implications for vaccines and therapy.
Bremermann HJ
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Aug; 9(5):459-83. PubMed ID: 7627623
[TBL] [Abstract][Full Text] [Related]
38. Induction of specific T-cell responses in HIV infection.
Leandersson AC; Bratt G; Hinkula J; Gilljam G; Cochaux P; Samson M; Sandström E; Wahren B
AIDS; 1998 Jan; 12(2):157-66. PubMed ID: 9468364
[TBL] [Abstract][Full Text] [Related]
39. Recognition of prominent viral epitopes induced by immunization with human immunodeficiency virus type 1 regulatory genes.
Hinkula J; Svanholm C; Schwartz S; Lundholm P; Brytting M; Engström G; Benthin R; Glaser H; Sutter G; Kohleisen B; Erfle V; Okuda K; Wigzell H; Wahren B
J Virol; 1997 Jul; 71(7):5528-39. PubMed ID: 9188627
[TBL] [Abstract][Full Text] [Related]
40. Analysis of HIV-1c-Specific CTL Responses with HIV-1 Reservoir Size and Forms.
Kang W; Zhu W; Li Y; Jiao Y; Zhuang Y; Xie Y; Zhao K; Dang B; Liu Q; Zhang Y; Sun Y
Viral Immunol; 2016 Apr; 29(3):184-91. PubMed ID: 26859257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
